Aquatic Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-252,888
Closed -$46.9M 1347
2025
Q2
$46.9M Buy
+252,888
New +$47M 0.95% 7
2024
Q4
Sell
-10,400
Closed -$2.05M 1289
2024
Q3
$2.05M Buy
+10,400
New +$1.94M 0.05% 358
2024
Q2
Sell
-134,400
Closed -$24.5M 1166
2024
Q1
$24.5M Buy
134,400
+81,900
+156% +$14.1M 0.8% 28
2023
Q4
$8.14M Sell
52,500
-210,300
-80% -$30.7M 0.21% 120
2023
Q3
$39.2M Buy
262,800
+11,400
+5% +$1.67M 1.63% 5
2023
Q2
$33.9M Buy
+251,400
New +$36.9M 1.83% 4

Other funds holding ABBV

Aquatic Capital Management's ABBV Position: Q3 2025 in Review

Aquatic Capital Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 252,888 shares — an estimated $46.9M sold.

Aquatic Capital Management first reported a position in ABBV in Q2 2023 and held it in 6 quarters. The position peaked at $46.9M in Q2 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Aquatic Capital Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 252,888 AbbVie shares in Q3 2025, an estimated $46.9M.
  • Aquatic Capital Management first reported a position in AbbVie in Q2 2023 and held it in 6 quarters.
  • Aquatic Capital Management's AbbVie position peaked at $46.9M in Q2 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Aquatic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.